Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Massimo Breccia, Matteo Molica, Irene Zacheo & Giuliana Alimena. (2014) Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy. Expert Opinion on Pharmacotherapy 15:11, pages 1621-1630.
Read now
Read now
Hussain I Saba. (2007) Decitabine in the treatment of myelodysplastic syndromes. Therapeutics and Clinical Risk Management 3:5, pages 807-817.
Read now
Read now
Sophie Kusy, Christian-Jacques Larsen & Joëlle Roche. (2004) p14ARF, p15INK4b and p16INK4a Methylation Status in Chronic Myelogenous Leukemia. Leukemia & Lymphoma 45:10, pages 1989-1994.
Read now
Read now
Bryan T Hennessy, Guillermo Garcia-Manero, Hagop M Kantarjian & Francis J Giles. (2003) DNA methylation in haematological malignancies: the role of decitabine. Expert Opinion on Investigational Drugs 12:12, pages 1985-1993.
Read now
Read now
Craig Rosenfeld & Hagop Kantarjian. (2001) Is Myelodysplastic Related Acute Myelogenous Leukemia a Distinct Entity from de novo Acute Myelogenous Leukemia? Potential for Targeted Therapies. Leukemia & Lymphoma 41:5-6, pages 493-500.
Read now
Read now
Articles from other publishers (36)
Mohammad Sadeghi, Mehrdad Fathi, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi, Mehdi Yousefi, Mohammad Hojjat-Farsangi, Afshin Namdar, Ali Akbar Movasaghpour Akbari & Farhad Jadidi-Niaragh. (2023) The prognostic and therapeutic potential of HO-1 in leukemia and MDS. Cell Communication and Signaling 21:1.
Crossref
Crossref
Alexandra Besser & Joyce Slingerland. 2023. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology
243
253
.
Fang Ye & Ningning Li. (2019) Role of p15(INK4B) Methylation in Patients With Myelodysplastic Syndromes: A Systematic Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 19:6, pages e259-e265.
Crossref
Crossref
Hong Wang, Yan Li, Na Lv, Yonghui Li, Lili Wang & Li Yu. (2018) Predictors of clinical responses to hypomethylating agents in acute myeloid leukemia or myelodysplastic syndromes. Annals of Hematology 97:11, pages 2025-2038.
Crossref
Crossref
Domenico Mattiucci, Giulia Maurizi, Pietro Leoni & Antonella Poloni. (2018) Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes. Cell Transplantation 27:5, pages 754-764.
Crossref
Crossref
Christopher J. Gibson, Benjamin L. Ebert & David P. Steensma. 2018. Hematology. Hematology
944
969.e13
.
A. Besser & J. Slingerland. 2016. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology
437
446
.
Jixue Zou, Zhigang Zhou, Liping Wan, Yin Tong, Youwen Qin, Chun Wang & Kun Zhou. (2015) Targeting the Sonic Hedgehog-Gli1 Pathway as a Potential New Therapeutic Strategy for Myelodysplastic Syndromes. PLOS ONE 10:8, pages e0136843.
Crossref
Crossref
Gabriela Bernadeta Iwanski, Nils Heinrich Thoennissen, Dorothy J. Park & H. Phillip Koeffler. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
455
486
.
Yue Wei, Irene Gañán-Gómez, Sophie Salazar-Dimicoli, Sara L McCay & Guillermo Garcia-Manero. (2011) Histone methylation in myelodysplastic syndromes. Epigenomics 3:2, pages 193-205.
Crossref
Crossref
Hsing-Chen Tsai & Stephen B Baylin. (2011) Cancer epigenetics: linking basic biology to clinical medicine. Cell Research 21:3, pages 502-517.
Crossref
Crossref
Patrick Brown, Gregory H. Reaman, Nita L. Seibel & Pamela Kearns. 2011. Childhood Leukemia. Childhood Leukemia
193
214
.
Pamela Kearns. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia
299
310
.
Lisa Pleyer, Daniel Neureiter, Victoria Faber & Richard Greil. 2010. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes
153
222
.
A. YALCIN, M. S. SERIN, G. EMEKDAS, N. TIFTIK, G. ASLAN, G. ESKANDARI & S. TEZCAN. (2009)
Promoter methylation of P15
INK4B
gene is possibly associated with parvovirus B19 infection in adult acute leukemias
. International Journal of Laboratory Hematology 31:4, pages 407-419.
Crossref
Crossref
Rebecca B. Klisovic, Wendy Stock, Spero Cataland, Marko I. Klisovic, Shujun Liu, William Blum, Margaret Green, Olatoyosi Odenike, Lucy Godley, Jennifer Vanden Burgt, Emily Van Laar, Michael Cullen, A. Robert Macleod, Jeffrey M. Besterman, Gregory K. Reid, John C. Byrd & Guido Marcucci. (2008) A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia. Clinical Cancer Research 14:8, pages 2444-2449.
Crossref
Crossref
Sotirios G. Papageorgiou, Stefanos Lambropoulos, Vassiliki Pappa, Christina Economopoulou, Frinta Kontsioti, Efstathios Papageorgiou, Panagiotis Tsirigotis, John Dervenoulas & Theofanis Economopoulos. (2007)
Hypermethylation of the
p15
INK4B
gene promoter in B‐chronic lymphocytic leukemia
. American Journal of Hematology 82:9, pages 824-825.
Crossref
Crossref
Margaret K. Yu. (2006) Epigenetics and chronic lymphocytic leukemia. American Journal of Hematology 81:11, pages 864-869.
Crossref
Crossref
Paresh Vyas & Alexander Sternberg. (2006) Characterization of the hemopoietic defect in early stages of the myelodysplastic syndromes. Advances in Enzyme Regulation 46:1, pages 98-112.
Crossref
Crossref
Ha Thanh Nishino & Chung-Che Chang. (2005) Myelodysplastic Syndromes: Clinicopathologic Features, Pathobiology, and Molecular Pathogenesis. Archives of Pathology & Laboratory Medicine 129:10, pages 1299-1310.
Crossref
Crossref
Sotirios G. Papageorgiou, Vassiliki Pappa, Efstathios Papageorgiou, Panagiotis Tsirigotis, Frida Kontsioti, Anna Panani, John Dervenoulas & Theofanis Economopoulos. (2005) Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes. European Journal of Haematology 75:3, pages 193-198.
Crossref
Crossref
Peter A. Jones. (2005) Overview of Cancer Epigenetics. Seminars in Hematology 42, pages S3-S8.
Crossref
Crossref
Takashi Shimamoto, Junko H. Ohyashiki & Kazuma Ohyashiki. (2005) Methylation of p15INK4b and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leukemia Research 29:6, pages 653-659.
Crossref
Crossref
David P. Steensma & Alan F. List. (2005) Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic Diversity. Mayo Clinic Proceedings 80:5, pages 681-698.
Crossref
Crossref
Gregory K. Reid & A. Robert MacLeod. 2005. DNA Methylation and Cancer Therapy. DNA Methylation and Cancer Therapy
187
204
.
Lewis R. Silverman. (2004) DNA methyltransferase inhibitors in myelodysplastic syndrome. Best Practice & Research Clinical Haematology 17:4, pages 585-594.
Crossref
Crossref
Ghulam J. Mufti. (2004) Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Practice & Research Clinical Haematology 17:4, pages 543-557.
Crossref
Crossref
Alison M John, N.Shaun B Thomas, Ghulam J Mufti & Rose Ann Padua. (2004) Targeted therapies in myeloid leukemia. Seminars in Cancer Biology 14:1, pages 41-62.
Crossref
Crossref
M Tessema, F Länger, J Dingemann, A Ganser, H Kreipe & U Lehmann. (2003) Aberrant methylation and impaired expression of the p15INK4b cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML). Leukemia 17:5, pages 910-918.
Crossref
Crossref
PETER A. JONES. (2003) Epigenetics in Carcinogenesis and Cancer Prevention. Annals of the New York Academy of Sciences 983:1, pages 213-219.
Crossref
Crossref
Long Wong, Joan Zhou, Daniel Anderson & Robert A Kratzke. (2002) Inactivation of p16INK4a expression in malignant mesothelioma by methylation. Lung Cancer 38:2, pages 131-136.
Crossref
Crossref
Jeffrey Gryn, Zella R. Zeigler, Richard K. Shadduck, John Lister, Jane M. Raymond, Ibrahim Sbeitan, Charles Srodes, Dennis Meisner & Cynthia Evans. (2002) Treatment of myelodysplastic syndromes with 5-azacytidine. Leukemia Research 26:10, pages 893-897.
Crossref
Crossref
Karim Roder, Maria-Jesus Latasa & Hei Sook Sul. (2002) Silencing of the Mouse H-rev107 Gene Encoding a Class II Tumor Suppressor by CpG Methylation. Journal of Biological Chemistry 277:34, pages 30543-30550.
Crossref
Crossref
Lewis R. Silverman. (2001) Targeting Hypomethylation of DNA to Achieve Cellular Differentiation in Myelodysplastic Syndromes (MDS). The Oncologist 6:S5, pages 8-14.
Crossref
Crossref
Lenka Krsková-Honzátková, Jaroslav Čermák, Jana Sajdová, Jan Starý, Petr Sedláček & Zuzana Sieglová. (2001) Loss of heterozygosity and heterogeneity of its appearance and persisting in the course of acute myeloid leukemia and myelodysplastic syndromes. Leukemia Research 25:1, pages 45-53.
Crossref
Crossref
Rose Ann Padua, Angela McGlynn & Hugh McGlynn. 2001. Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia. Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia
111
157
.